ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
28 announcements with these filters
Promoter Vicky Hemchand Gala purchased 3,500 shares of Valiant Organics via a market transaction. This increases the promoter's stake by 0.01%.
Promoter Vicky Hemchand Gala acquired 3,500 shares of Valiant Organics Ltd via a market purchase. This increases the promoter's holding from 0.92% to 0.93%.
Designated Person Siddharth Dinesh Shah HUF acquired 1,000 shares of Valiant Organics Ltd through a market purchase, valued at Rs. 3,27,350.00.
Valiant Organics Ltd filed a Regulation 7(2) PIT disclosure reporting equity trades executed by designated persons Siddharth Dinesh Shah HUF and Ishita Siddharth Shah.
Valiant Organics Limited issued a notice for its Annual General Meeting scheduled on September 29, 2026, to approve financial statements and related party transactions.
Valiant Organics has filed its Annual Report and Notice of the 21st Annual General Meeting for the financial year 2025-26.
Valiant Organics reported a strong Q1-FY27 with revenue reaching INR 2,315 Mn and EBITDA margins expanding to 17.97%, the highest in six quarters, driven by raw material savings and operating leverage.
Valiant Organics Limited announced the re-appointment of Mr. Sathiababu K. Kallada as Executive Director for a 36-month term effective May 24, 2027.
Valiant Organics has granted 18,000 Employee Stock Options to an eligible employee under its 2022 ESOP Scheme. The exercise price per option is Rs. 10.
Valiant Organics Ltd reported revenue from operations of ₹231.5 Cr (+13.3% YoY) and net profit of ₹29.3 Cr (+257.3% YoY) for Q1 FY27.
Valiant Organics Limited scheduled a board meeting on August 12, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
CRISIL Ratings reaffirmed the credit ratings of Valiant Organics Limited, revising the outlook to 'Stable'. The total bank loan facilities rated are Rs. 370 Crore.
CRISIL Ratings reaffirmed credit ratings for Valiant Organics Ltd's bank facilities and revised the long-term outlook to 'Stable'. The total rated facility is ₹370 Crore.
The company filed its quarterly shareholding pattern for June 2026. It also reported the allotment of 15,000 equity shares upon the exercise of employee stock options.
Valiant Organics reported a significant FY26 turnaround with Revenue of ₹7,388 Mn (+3% YoY) and PAT of ₹332 Mn, recovering from a loss. Performance was driven by structural cost optimization and improved realizations.
Valiant Organics issued a postal ballot for a ₹96.05 Crore related party transaction and subsidiary partnership cessation. Shareholders will vote on these material structural changes.
Valiant Organics Limited issued a postal ballot notice for member approval of two resolutions. The matters include ceasing as a partner in Dhanvallabh Ventures LLP.
Valiant Organics issued a corrigendum clarifying a material related party transaction with DVLLP involving a ₹6.34 Crore payment. The transaction includes transferring 1,86,07,531 shares.
Valiant Organics Limited will acquire 1,86,07,531 equity shares of Valiant Laboratories Limited off-market for ₹116.69 Crore. The acquisition facilitates internal restructuring within the promoter group.
Valiant Organics will exit its subsidiary Dhanvallabh Ventures LLP. Consideration involves receiving 1,86,07,531 shares of Valiant Laboratories Limited upon completion.
Valiant Organics is evaluating restructuring options to simplify its corporate structure and achieve strategic synergies. The board has granted in-principle approval for this strategic realignment.
Valiant Organics Ltd reported revenue from operations of ₹217.8 Cr (+6.9% YoY) and net profit of ₹15.7 Cr (+273.8% YoY) for Q4 FY26.
Valiant Organics reported standalone annual total income of ₹745.29 Crore and approved pharma business as a reportable segment. Auditors issued an unmodified opinion for FY26.
Valiant Organics Limited's board approved exploring internal restructuring options to achieve strategic synergies. The evaluation aims to unlock shareholder value through simplified holding structures.
Valiant Organics has re-appointed Manish Modi and Associates as Internal Auditors and Ketki D. Visariya as Cost Auditors. Both appointments are for 12-month terms effective April 1, 2026.
Valiant Organics reappointed Manish Modi and Associates as Internal Auditors and Ms. Ketki D. Visariya as Cost Auditors. Both appointments span 12-month terms starting April 2026.
Valiant Organics granted 19,500 employee stock options at Rs.10 each. The move aims to retain talent and align employee interests with shareholder value.
Valiant Organics scheduled a board meeting for May 16, 2026, to approve audited annual financial results. The company's trading window remains closed until May 18.